Global /Canada /Healthcare /Drug Manufacturers - Specialty & Generic /IAN
chevron_leftBack

iAnthus Capital Holdings, Inc.

IAN
CSE: IAN Delayed
0.0100CAD 0%
0.0072 USD
As of 24 April 2025, iAnthus Capital Holdings, Inc. has a market cap of $48.71M USD, ranking #24915 globally and #745 in Canada. It ranks #2528 in the Healthcare sector, and #557 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
24915
Country Rank
745
Sector Rank
2528
Industry Rank
557
Key Stats
Market Cap
$48.71MUSD
67.46M CAD
Enterprise Value
$247.58MUSD
343.59M CAD
Revenue (TTM)
$173.27MUSD
239.95M CAD
EBITDA (TTM)
$12.55MUSD
17.42M CAD
Net Income (TTM)
-$7.93MUSD
-10.99M CAD
EBITDA Margin
7.3%
Profit Margin
-4.6%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard Proud open_in_new
Employees
834
Founded
2014
Website
ianthus.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 100% 100% 100% 0% -60%

Markets

Exchange Ticker Price
Canadian Securities Exchange
MIC: XCNQ
PRIMARY
IAN
iAnthus Capital Holdings Inc
ISIN: CA45074T1021
Shares Out.:
6.746B1 Shares Float: 3.859B2
TV:
SA:
YF:
GF:
BA:
IAN
MS:
0.0100 CAD
Cboe Canada
MIC: NEOE
IAN
iAnthus Capital Holdings Inc
ISIN: CA45074T1021
TV:
SA:
YF:
GF:
BA:
IAN
MS:
0.0100 CAD
OTC Markets
MIC: OTCM
ITHUF
iAnthus Capital Holdings Inc
ISIN: CA45074T1021
TV:
SA:
YF:
GF:
BA:
MS:
0.0051 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About iAnthus Capital Holdings, Inc.

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. The company also develops, produces, and distributors of branded cannabis products. It offers cannabis flower and trims, such as packaged flowers and pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures. The company was formerly known as Ianthus Capital Management LLC and changed its name to iAnthus Capital Holdings, Inc. in August 2016. iAnthus Capital Holdings, Inc. was founded in 2014 and is headquartered in Toronto, Canada.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Canada)
Name
Market Cap diff.
Bausch Health Companies Inc.
BHC
$1.91B
2.65B CAD
4K%
Cronos Group Inc.
CRON
$685.03M
948.68M CAD
1K%
DRI HEALTHCARE TRUST
DHT.U
$631.25M
1K%
Tilray Brands, Inc.
TLRY
$438.92M
801%
Knight Therapeutics Inc.
GUD
$411.13M
569.37M CAD
744%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
138K%
Merck KGaA
MRK
$59.42B
52.43B EUR
122K%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
101K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
95K%
Haleon plc
HLN
$45.57B
34.34B GBP
93K%